Dicot Pharma AB (STO:DICOT)
Sweden
· Delayed Price · Currency is SEK 0.295
-0.009 (-2.81%)
At close: Mar 9, 2026
Dicot Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 69.2 | 113.42 | 47.34 | 9.38 | 30.33 | Upgrade
|
| Cash & Short-Term Investments | 69.2 | 113.42 | 47.34 | 9.38 | 30.33 | Upgrade
|
| Cash Growth | -38.99% | 139.58% | 404.88% | -69.08% | 49.20% | Upgrade
|
| Other Receivables | 8.3 | 3.47 | 2.3 | 1.14 | 1.01 | Upgrade
|
| Receivables | 8.3 | 3.47 | 2.3 | 1.14 | 1.01 | Upgrade
|
| Inventory | 8 | 5.38 | 3.4 | 1.49 | - | Upgrade
|
| Prepaid Expenses | - | 1.35 | 0.5 | 0.34 | 0.4 | Upgrade
|
| Other Current Assets | - | - | -0 | - | - | Upgrade
|
| Total Current Assets | 85.5 | 123.62 | 53.54 | 12.35 | 31.74 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.01 | 0.02 | 0.03 | Upgrade
|
| Total Assets | 85.5 | 123.62 | 53.56 | 12.37 | 31.77 | Upgrade
|
| Accounts Payable | - | 6.84 | 4.54 | 3.42 | 2.58 | Upgrade
|
| Accrued Expenses | - | 4.05 | 3.98 | 1.19 | 0.66 | Upgrade
|
| Other Current Liabilities | 12.1 | 1.07 | 0.64 | 2.41 | 0.19 | Upgrade
|
| Total Current Liabilities | 12.1 | 11.96 | 9.16 | 7.01 | 3.42 | Upgrade
|
| Total Liabilities | 12.1 | 11.96 | 9.16 | 7.01 | 3.42 | Upgrade
|
| Common Stock | 14.1 | 12.45 | 5.72 | 17.14 | 12.86 | Upgrade
|
| Additional Paid-In Capital | 339.3 | 299 | 180.76 | 86.15 | 81.67 | Upgrade
|
| Retained Earnings | - | -199.79 | -142.09 | -97.93 | -66.18 | Upgrade
|
| Comprehensive Income & Other | -280 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 73.4 | 111.67 | 44.39 | 5.36 | 28.35 | Upgrade
|
| Total Liabilities & Equity | 85.5 | 123.62 | 53.56 | 12.37 | 31.77 | Upgrade
|
| Net Cash (Debt) | 69.2 | 113.42 | 47.34 | 9.38 | 30.33 | Upgrade
|
| Net Cash Growth | -38.99% | 139.58% | 404.88% | -69.08% | 49.20% | Upgrade
|
| Net Cash Per Share | 0.04 | 0.10 | 0.09 | 0.08 | 0.47 | Upgrade
|
| Filing Date Shares Outstanding | 2,009 | 1,779 | 817.56 | 137.1 | 102.9 | Upgrade
|
| Total Common Shares Outstanding | 2,009 | 1,779 | 817.56 | 137.1 | 102.9 | Upgrade
|
| Working Capital | 73.4 | 111.67 | 44.38 | 5.34 | 28.32 | Upgrade
|
| Book Value Per Share | 0.04 | 0.06 | 0.05 | 0.04 | 0.28 | Upgrade
|
| Tangible Book Value | 73.4 | 111.67 | 44.39 | 5.36 | 28.35 | Upgrade
|
| Tangible Book Value Per Share | 0.04 | 0.06 | 0.05 | 0.04 | 0.28 | Upgrade
|
| Machinery | - | - | 0.04 | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.